TaVNS for Acute Intracerebral Hemorrhage

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 186 participants.

Also called NCT06918964

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 186 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06918964
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06918964. Randomized; double masking; primary purpose treatment. Start 2025-09-15 (actual); primary completion 2028-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TaVNS for Acute Intracerebral Hemorrhage
Acronym
TAVANS-ICH
Condition
Intracerebral Hemorrhage
Intervention (Device)
transcutaneous auricular vagus nerve stimulation device
Intervention (Device)
Sham device
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct06918964
Content hash
b6d0c5a7f13cf59ad02fff60c4b43060636983c213eaa528cdd524bef3a2b123